Investment Team
Partner, Co-Head Flagship Fund
Judith Charpentier has over 17 years of private equity experience. Since joining the firm in 2009, Judith has played a pivotal role in shaping Astorg’s investment strategies and sector expertise. She has founded Astorg’s Healthcare practice in 2016 and continuously developed it since then. Leveraging her deep expertise in Healthcare, Judith has built a strong track record and made the firm a reference in the sector. Under her leadership, Astorg has invested over €6.5 billion in Healthcare, becoming its largest sector, with notable investments including Clario, CordenPharma, Nexpring, OPEN Health, Cytel, Echosens, HRA Pharma - several of which she has directly sourced and led.
She has been an active member of the Investment Committee since 2021. In addition to her investment responsibilities, she has taken broader managerial roles and functions, becoming Co-Head of the firm’s Flagship Fund in 2023. Recognized as a key leader within the firm, Judith was appointed to Astorg’s Executive Committee in April 2024.
Nexpring Health
Nexpring Health is a global leader in Assisted Reproductive Technology(ART), providing consumables and equipment for in-vitro fertilization(IVF) procedures to hospitals, clinics and IVF labs across 115+ countries.
Investment year: 2024
Healthcare In Portfolio
OPEN Health
OPEN Health is a global leading medical affairs and market access platform serving the pharma industry.
Investment year: 2022
Healthcare In Portfolio
CordenPharma
CordenPharma is a leading CDMO focused on fast-growing complex niche drug modalities with end to end capabilities from early stage development to commercial large-scale manufacturing.
Investment year: 2022
Healthcare In Portfolio
Cytel
Cytel is widely recognized as the industry pioneer of adaptive clinical trials technology and a thought-leader in biostatistical science.
Investment year: 2021
Healthcare In Portfolio
Demetra
Demetra is a world-leading player in the bone cement and biomaterials space, serving all the major players in the orthopaedic industry.
Investment year: 2021
Healthcare In Portfolio
Clario
Clario delivers leading endpoint technology solutions for clinical trials.
Investment year: 2020
Healthcare In Portfolio
Echosens
Echosens is a specialized diagnostic company providing non-invasive medical devices and services to support physicians in their diagnostic and monitoring of chronic liver diseases.
Investment year: 2018
Healthcare In Portfolio
HRA Pharma
HRA is an innovative OTC pharma company with leading positions in Europe and in the US.
Investment year: 2016
Healthcare Realised